INCYTE CORP

Services-Commercial Physical & Biological Research·WILMINGTON, DE·FY end 12/31·CIK 879169

CEO Pay Ratio

47:1

William J. Meury

CEO Total Comp

—

William J. Meury

Median Employee

$295,914

Revenue

$5.1B

FY 2025

Net Income

$1.3B

FY 2025

Free Cash Flow

—

FY 2025

Net Margin

25.0%

Insider Net (180d)

0 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income

—

Not enough data to compute.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$5.1B	$4.2B	$3.7B	$3.4B	$3.0B
Gross Profit	—	—	—	—	—	—
Operating Income	$1.5B	$61.4M	$620.5M	$579.4M	$585.8M
Net Income	$1.3B	$32.6M	$597.6M	$340.7M	$948.6M
Operating CF	$1.4B	$335.3M	$496.5M	$969.9M	$749.5M
Capex	—	$48.7M	—	—	—	—
Free Cash Flow	—	$286.6M	—	—	—	—
Buybacks	$0	$2.0B	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	29.5%	1.4%	16.8%	17.1%	19.6%
Net Margin	25.0%	0.8%	16.2%	10.0%	31.8%
FCF Margin	—	6.8%	—	—	—	—
R&D / Revenue	39.9%	61.5%	44.0%	46.7%	48.8%
Effective Tax	22.7%	89.7%	28.4%	35.6%	-66.3%
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	—	699.4%	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Steven H. SteinExecutive Vice President, Chief Medical Officer and Head of Late-stage Development	$835.1K	$3.5M	$1.3M	$696.1K	$35.8K	$6.3M
William J. Meury · CEO	—	—	—	—	—	—